SuanFarma-Header SuanFarma-Header


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type


            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Lead Product(s): EVX-01

            Therapeutic Area: Oncology Product Name: EVX-01

            Highest Development Status: Phase I/ Phase II Product Type: Peptide

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable July 07, 2021


            EVX-01, a novel personalized cancer neoepitope immunotherapy based on Evaxion’s PIONEER artificial intelligence (AI) technology is being developed for the treatment of patients with melanoma, non-small cell lung cancer (NSCLC) and bladder cancer.